William Wachsman

University of California San Diego Medical Center

Immunology and MicrobiologyMedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma”.

AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-0645

N/A

0.560DataRank · unranked

15 citations

Kelly A. Shimabukuro, Page C. Moore, Richard F. Ambinder, Jack D. Bui, Semi Han +9 more

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma

Haematologica(2020)10.3324/haematol.2019.243386

N/A

0.425DataRank · unranked

16 citations

Jeannette Y. Lee, Lawrence D. Kaplan, Juan Carlos Ramos, Richard F. Ambinder, William Wachsman +8 more

Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1142

N/A

0DataRank · unranked

3 citations

Jeannette Y. Lee, Elizabeth Y. Chiao, David M. Aboulafia, Lee Ratner, Richard F. Ambinder +6 more